658 A phase 2 study to assess the safety, efficacy of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancerPaul Rhee, Michael Chisamore, Min Hee Ryu et al.|Regular and Young Investigator Award Abstracts|2022Cited by 2